These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35502467)

  • 1. Criminal Action Against Drug Counterfeiters: Assessment of the FDA Office of Criminal Investigation Database 2016 Through 2021.
    White CM
    Ann Pharmacother; 2022 Dec; 56(12):1333-1338. PubMed ID: 35502467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks.
    Jackson G; Arver S; Banks I; Stecher VJ
    Int J Clin Pract; 2010 Mar; 64(4):497-504. PubMed ID: 20088883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caveat oncologist: clinical findings and consequences of distributing counterfeit erythropoietin in the United States.
    Qureshi ZP; Norris L; Sartor O; McKoy JM; Armstrong J; Raisch DW; Garg V; Stafkey-Mailey D; Bennett CL
    J Oncol Pract; 2012 Mar; 8(2):84-90. PubMed ID: 23077434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the problem of counterfeit medications in the United Kingdom.
    Jackson G; Patel S; Khan S
    Int J Clin Pract; 2012 Mar; 66(3):241-50. PubMed ID: 22070229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-counterfeit activities of pharmaceutical companies in Japan: for patient safety].
    Shofuda K; Aragane K; Igari Y; Matsumoto K; Ito K
    Yakugaku Zasshi; 2014; 134(2):203-11. PubMed ID: 24492224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Counterfeit medicines--Japan and the world].
    Sato D
    Yakugaku Zasshi; 2014; 134(2):213-22. PubMed ID: 24492225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Counterfeit drugs in Israel and worldwide. Part II: distribution profile and anti-counterfeiting strategies and actions].
    Furman-Assaf S; Tamir O; Marom E; Arieli M; Shemer J
    Harefuah; 2010 Jul; 149(7):470-5, 479. PubMed ID: 21465764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles for pharmacy in combatting counterfeit drugs.
    Ziance RJ
    J Am Pharm Assoc (2003); 2008; 48(4):e71-88; quiz e89-91. PubMed ID: 18653407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism.
    Mackey TK; Liang BA
    BMC Med; 2013 Oct; 11():233. PubMed ID: 24228892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counterfeit Avastin in India: Punish the Criminals, Not the Patients.
    Stewart MW; Narayanan R; Gupta V; Rosenfeld PJ; Martin DF; Chakravarthy U
    Am J Ophthalmol; 2016 Oct; 170():228-231. PubMed ID: 27287822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the pharmacist in preventing distribution of counterfeit medications.
    Chambliss WG; Carroll WA; Kennedy D; Levine D; Moné MA; Ried LD; Shepherd M; Yelvigi M
    J Am Pharm Assoc (2003); 2012; 52(2):195-9. PubMed ID: 22370383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on counterfeit antibiotics worldwide; public health risks.
    Delepierre A; Gayot A; Carpentier A
    Med Mal Infect; 2012 Jun; 42(6):247-55. PubMed ID: 22621827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in FDA enforcement activities following changes in federal administration: the case of regulatory letters released to pharmaceutical companies.
    Nguyen D; Seoane-Vazquez E; Rodriguez-Monguio R; Montagne M
    BMC Health Serv Res; 2013 Jan; 13():27. PubMed ID: 23339419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adulterated and Counterfeit Male Enhancement Nutraceuticals and Dietary Supplements Pose a Real Threat to the Management of Erectile Dysfunction: A Global Perspective.
    ElAmrawy F; ElAgouri G; Elnoweam O; Aboelazayem S; Farouk E; Nounou MI
    J Diet Suppl; 2016 Nov; 13(6):660-93. PubMed ID: 26913542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counterfeiting of drugs in Brazil.
    Ames J; Souza DZ
    Rev Saude Publica; 2012 Feb; 46(1):154-9. PubMed ID: 22218762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Counterfeit phosphodiesterase type 5 inhibitors--growing safety risks for public health].
    Fijałek Z; Sarna K; Błazewicz A; Marin J
    Rocz Panstw Zakl Hig; 2010; 61(3):227-35. PubMed ID: 21365856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The economics of counterfeit Avastin: a geospatial and statistical analysis of demographic correlates to FDA warning letters.
    Cuomo RE; Mackey TK; Stigler P
    Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):748-56. PubMed ID: 26016718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fentanyl, Heroin, and Methamphetamine-Based Counterfeit Pills Sold at Tourist-Oriented Pharmacies in Mexico: An Ethnographic and Drug Checking Study.
    Friedman J; Godvin M; Molina C; Romero R; Borquez A; Avra T; Goodman-Meza D; Strathdee S; Bourgois P; Shover CL
    medRxiv; 2023 May; ():. PubMed ID: 36747647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.